Malaysian Consensus Statement for the Diagnosis and Management of Acromegaly

In Malaysia, acromegaly is under-recognised with only 10-15% of the expected number of cases from prevalence estimates, having been diagnosed and managed in established endocrine centres with access to multidisciplinary care. This is mainly due to lack of awareness and standardised approach in diagn...

Descripción completa

Detalles Bibliográficos
Autores principales: Hussein, Zanariah, Bidin, Mohamed Long, Alias, Azmi, Thiagarajan, Muthukkumaran, Latif, Kartikasalwah Abdul, Ratnasingam, Jeyakantha, Seman, Wan Juani Wan, Nasruddin, Azraai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Journal of the ASEAN Federation of Endocrine Societies 2019
Materias:
Feature Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7784186/
https://www.ncbi.nlm.nih.gov/pubmed/33442131
http://dx.doi.org/10.15605/jafes.034.01.03
Descripción
Sumario:In Malaysia, acromegaly is under-recognised with only 10-15% of the expected number of cases from prevalence estimates, having been diagnosed and managed in established endocrine centres with access to multidisciplinary care. This is mainly due to lack of awareness and standardised approach in diagnosing this disease resulting in delay in diagnosis and management with suboptimal treatment outcomes. This first Malaysian consensus statement on the diagnosis and management of acromegaly addresses these issues and is based on current best practices and latest available evidence so as to reduce the disease burden on acromegaly patients managed in the Malaysian healthcare system.

Ejemplares similares